SCHEMBL1948946

SCHEMBL1948946

CCCC(=O)ON(C(=O)O)S(=O)(=O)c1ccccc1S(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
BAZ2B Q9UIF8 2/20 0.35
BCAT2 O15382 1/20 0.35
ESR1 P03372 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 2/20 0.34
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
TRIM24 O15164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1927510 0.89 BMP1 (0.37) BMP1TDP1BCAT2ALDH1A1
SCHEMBL1925989 0.87 BMP1 (0.36) BMP1TDP1BCAT2
SCHEMBL1948803 0.87 TDP1 (0.45) BMP1TDP1ALDH1A1MEN1KMT2A
SCHEMBL1948893 0.85 L3MBTL1 (0.49) TDP1POLBMAPTALDH1A1MEN1
SCHEMBL1948733 0.85 BMP1 (0.42) BMP1TDP1NPC1RAB9AKMT2A
SCHEMBL1952112 0.84 BMP1 (0.38) BMP1TDP1BCAT2TP53NPC1
SCHEMBL1925443 0.81 KMT2A (0.41) BMP1TDP1BAZ2BBCAT2ALDH1A1
SCHEMBL1950189 0.79 ITGAV (0.40) BMP1TDP1BCAT2MAPTALDH1A1
SCHEMBL1949476 0.79 HSD11B1 (0.38) BMP1BCAT2ALDH1A1MEN1NPC1
SCHEMBL1926036 0.78 HSD11B1 (0.40) BMP1TDP1BCAT2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150197502-A1 Bis-Acylated Hydroxylamine Derivatives THE JOHNS HOPKINS UNIVERSITY 2015-07-16 US claimed
EP-2509942-A2 BIS-ACYLATED HYDROXYLAMINE DERIVATIVES Johns Hopkins University (US) 2012-10-17 EP claimed
WO-2011071947-A2 BIS-ACYLATED HYDROXYLAMINE DERIVATIVES JOHNS HOPKINS UNIVERSITY (US) 2011-06-16 WO claimed
US-20110136827-A1 Bis-Acylated Hydroxylamine Derivatives THE JOHNS HOPKINS UNIVERSITY 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197502-A1 Bis-Acylated Hydroxylamine Derivatives CPT1A, TNNI3, NOS2 BMP1 3173/4885TDP1 1834/4885BAZ2B 1362/4885
US-20110136827-A1 Bis-Acylated Hydroxylamine Derivatives CPT1A, TNNI3, NOS2 BMP1 3173/4885TDP1 1834/4885BAZ2B 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.